These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 25054864)

  • 1. Strategic focus on 3R principles reveals major reductions in the use of animals in pharmaceutical toxicity testing.
    Törnqvist E; Annas A; Granath B; Jalkesten E; Cotgreave I; Öberg M
    PLoS One; 2014; 9(7):e101638. PubMed ID: 25054864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Working in partnership to advance the 3Rs in toxicity testing.
    Holmes AM; Creton S; Chapman K
    Toxicology; 2010 Jan; 267(1-3):14-9. PubMed ID: 19903508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refinement, reduction, and replacement of animal use for regulatory testing: future improvements and implementation within the regulatory framework.
    Richmond J
    ILAR J; 2002; 43 Suppl():S63-8. PubMed ID: 12388854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory Acceptance of Alternative Methods in the Development and Approval of Pharmaceuticals.
    Beken S; Kasper P; van der Laan JW
    Adv Exp Med Biol; 2016; 856():33-64. PubMed ID: 27671719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimising the design of preliminary toxicity studies for pharmaceutical safety testing in the dog.
    Smith D; Combes R; Depelchin O; Jacobsen SD; Hack R; Luft J; Lammens L; von Landenberg F; Phillips B; Pfister R; Rabemampianina Y; Sparrow S; Stark C; Stephan-Gueldner M
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):95-101. PubMed ID: 15698532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How omics technologies can contribute to the '3R' principles by introducing new strategies in animal testing.
    Kroeger M
    Trends Biotechnol; 2006 Aug; 24(8):343-6. PubMed ID: 16782220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical safety evaluation using nonrodent species: an industry/welfare project to minimize dog use.
    Smith D; Broadhead C; Descotes G; Fosse R; Hack R; Krauser K; Pfister R; Phillips B; Rabemampianina Y; Sanders J; Sparrow S; Stephan-Gueldner M; Jacobsen SD
    ILAR J; 2002; 43 Suppl():S39-42. PubMed ID: 12388850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of the 3Rs (refinement, reduction, and replacement): validation and regulatory acceptance considerations for alternative toxicological test methods.
    Schechtman LM
    ILAR J; 2002; 43 Suppl():S85-94. PubMed ID: 12388858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing alternatives to systemic toxicity testing approaches.
    von Aulock S
    ALTEX; 2012; 29(1):1. PubMed ID: 22408846
    [No Abstract]   [Full Text] [Related]  

  • 10. Humane science finds sharper and kinder tools.
    Stokstad E
    Science; 1999 Nov; 286(5442):1068-71. PubMed ID: 10610517
    [No Abstract]   [Full Text] [Related]  

  • 11. Making progress and gaining momentum in global 3Rs efforts: how the European pharmaceutical industry is contributing.
    Fleetwood G; Chlebus M; Coenen J; Dudoignon N; Lecerf C; Maisonneuve C; Robinson S
    J Am Assoc Lab Anim Sci; 2015 Mar; 54(2):192-7. PubMed ID: 25836966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent efforts to elucidate the scientific validity of animal-based drug tests by the pharmaceutical industry, pro-testing lobby groups, and animal welfare organisations.
    Bailey J; Balls M
    BMC Med Ethics; 2019 Mar; 20(1):16. PubMed ID: 30823899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ["Replacement Methods to Animal Testing" as the incentive topic of the German Ministry of Education and Research. Selected results on biological drugs].
    Diekmann W; Hansper M
    ALTEX; 2001; 18(1):23-8. PubMed ID: 11248846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncertainty of testing methods--what do we (want to) know?
    Paparella M; Daneshian M; Hornek-Gausterer R; Kinzl M; Mauritz I; Mühlegger S
    ALTEX; 2013; 30(2):131-44. PubMed ID: 23665803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal experimentation: implementation and application of the 3Rs.
    Lewis DI
    Emerg Top Life Sci; 2019 Nov; 3(6):675-679. PubMed ID: 32915219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ANIMAL WELFARE FROM MOUSE TO MOOSE--IMPLEMENTING THE PRINCIPLES OF THE 3RS IN WILDLIFE RESEARCH.
    Lindsjö J; Fahlman Å; Törnqvist E
    J Wildl Dis; 2016 Apr; 52(2 Suppl):S65-77. PubMed ID: 26845301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. It's Time to Reconsider
    Balls M
    Altern Lab Anim; 2020 Jan; 48(1):40-46. PubMed ID: 32316753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation.
    De Wever B; Fuchs HW; Gaca M; Krul C; Mikulowski S; Poth A; Roggen EL; Vilà MR
    Toxicol In Vitro; 2012 Apr; 26(3):526-34. PubMed ID: 22269383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scientific procedures on living animals in Great Britain 2003.
    Altern Lab Anim; 2005 Apr; 33(2):83-8. PubMed ID: 16189908
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.